Public Policy Page Contents
- PSAB Documents (Statements, Reports, Testimony and Monthly Newsletters)
- Research and Development Funding for FY 2015
- Contact Congress (Legislative Action Center)
- Clinical Microbiology Resources
- Public and Scientific Affairs Board Information
- Federal and State Government Links
- Congressional Science Fellowship
Check Here for Critical Public Policy Information
- Sentinel Level Clinical Laboratory Protocols For Suspected Biological Threat Agents And Emerging Infectious Diseases
- Committee on the Status of Women in Microbiology
- Committee on Microbiological Issues Impacting Minorities
Public and Scientific Affairs Board (PSAB)
Underlying the ASM's dedication to the advancement of scientific knowledge is its commitment that science serve the public interest. To address scientific matters affecting the public interest, the ASM created the Public and Scientific Affairs Board (PSAB) in 1979. The PSAB monitors legislation and regulation and develops positions for the Society on public policy issues. The PSAB encourages the adoption of sound policies affecting science and technology and the discipline of microbiology. The PSAB responds to policy makers who may request or require an understanding of research and technology in microbiology. It also communicates microbiological issues to the public.
What's New in Public Policy?
The March issue of the e-Public Policy Update has been published by the Office of Public Affairs. The content of this page is restricted to ASM Members only.Please login at the top-right or to become a member, join ASM.
The ASM sent a letter to Senator Tom Harkin thanking him for the Accelerating Biomedical Research Act and his leadership regarding funding for the National Institutes of Health.
The ASM sent the following statement to ASM members regarding the recent biosafety lapses.
The July issue of the Minority Microbiology Mentor has been published by the Committee on Microbiological Issues Impacting Minorities.
ASM provided comments to the Centers for Medicare & Medicaid Services (CMS) regarding Section 1834A, “Improving Policies for Clinical Diagnostic Laboratory Tests,” added to the Social Security Law by the Protecting Access to Medicare Act of 2014 (PAMA).
The ASM presented recommendations to the Centers for Medicare & Medicaid Services at its annual public meeting on payment levels for new tests to be included in the 2015 Clinical Laboratory Fee Schedule.
The June issue of the Clinical Microbiology Issues Update has been published by the Office of Public Affairs. The content of this page is restricted to ASM Members only.Please login at the top-right or to become a member, join ASM.
The ASM sent a letter to the House Science, Space and Technology Committee regarding the DOE authorization bill that would make significant cuts in R&D funding for the energy and environmental sciences.
ASM and CLSI Release White Paper on MSSA and Ceftriaxone EtestsThe PSAB Committee on Laboratory Practices and the Clinical Laboratory Standards Institute (CLSI) have prepared MSSA and Ceftriaxone Etest issue: CLSI & ASM White Paper to discuss claims in a retracted paper that 60% of methicillin sensitive S. aureus (MSSA)...
The ASM joined 50 other organizations in a campaign to highlight Closing the Innovation Deficit.